Genzyme Sues Roxane Again Over Generic Hectorol
Biotechnology company Genzyme Corp. has launched another patent infringement suit over Roxane Laboratories Inc.'s plans to market a generic version of chronic kidney disease treatment Hectorol....To view the full article, register now.
Already a subscriber? Click here to view full article